10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of GEM-X, the next generation of the...

Related Keywords

,Michael Schnall Levin ,Nasdaq ,Securities Exchange ,Genomics Inc ,Exchange Commission ,Founding Scientist ,Chief Technology Officer ,Chromium Single Cell Gene Expression ,Chromium Single Cell Immune Profiling ,Chromiumx Series ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Financial Condition ,